Handbook of Cancer Treatment Related Toxicities

Handbook of Cancer Treatment Related Toxicities
Author: Vamsidhar Velcheti,Vamsidhar Velcheti, MD, FACP, FCCP,Salman R. Punekar
Publsiher: Unknown
Total Pages: 466
Release: 2021-02-12
ISBN 10: 9780323672412
ISBN 13: 0323672418
Language: EN, FR, DE, ES & NL

Handbook of Cancer Treatment Related Toxicities Book Review:

Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Handbook of Cancer Treatment Related Symptoms and Toxicities E Book

Handbook of Cancer Treatment Related Symptoms and Toxicities E Book
Author: Vamsidhar Velcheti,Salman R Punekar
Publsiher: Elsevier Health Sciences
Total Pages: 352
Release: 2021-01-28
ISBN 10: 032367299X
ISBN 13: 9780323672993
Language: EN, FR, DE, ES & NL

Handbook of Cancer Treatment Related Symptoms and Toxicities E Book Book Review:

Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies.

Skeel s Handbook of Cancer Therapy

Skeel s Handbook of Cancer Therapy
Author: Samir N. Khleif,Olivier Rixe,Roland Skeel
Publsiher: Lippincott Williams & Wilkins
Total Pages: 832
Release: 2016-03-31
ISBN 10: 1496353390
ISBN 13: 9781496353399
Language: EN, FR, DE, ES & NL

Skeel s Handbook of Cancer Therapy Book Review:

For more than 30 years, Skeel’s Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including innovations in immunotherapy, oncology genomics, and molecular targeted therapy. An invaluable reference for all levels of physicians, nurses, and allied health professionals who provide care to cancer patients, this bestselling guide combines the most current rationale and the details necessary to safely administer pharmacologic therapy, offering a balanced synthesis between science and clinical practice.

Handbook of Cancer Chemotherapy

Handbook of Cancer Chemotherapy
Author: Roland T. Skeel
Publsiher: Lippincott Williams & Wilkins
Total Pages: 817
Release: 2007
ISBN 10: 9780781765312
ISBN 13: 0781765315
Language: EN, FR, DE, ES & NL

Handbook of Cancer Chemotherapy Book Review:

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Handbook of Cancer Survivorship

Handbook of Cancer Survivorship
Author: Michael Feuerstein,Larissa Nekhlyudov
Publsiher: Springer
Total Pages: 419
Release: 2018-10-31
ISBN 10: 3319774328
ISBN 13: 9783319774329
Language: EN, FR, DE, ES & NL

Handbook of Cancer Survivorship Book Review:

This timely revision of the authoritative handbook gives a wide range of providers practical insights and strategies for treating cancer survivors’ long-term physical and mental health issues. Details of new and emerging trends in research and practice enhance readers’ awareness of cancer survivor problems so they may better detect, monitor, intervene in, and if possible prevent disturbing conditions and potentially harmful outcomes. Of particular emphasis in this model of care are recognizing each patient’s uniqueness within the survivor population and being a co-pilot as survivors navigate their self-management. New or updated chapters cover major challenges to survivors’ quality of life and options for service delivery across key life domains, including: Adaptation and coping post-treatment. Problems of aging in survivorship, disparities and financial hardship. Well-being concerns including physical activity, weight loss, nutrition, and smoking cessation. Core functional areas such as work, sleep, relationships, and cognition. Large-scale symptoms including pain, distress, and fatigue. Models of care including primary care and comprehensive cancer center. International perspectives PLUS, insights about lessons learned and challenges ahead. With survivorship and its care becoming an ever more important part of the clinical landscape, the Second Edition of the Handbook of Cancer Survivorship is an essential reference for oncologists, rehabilitation professionals, public health, health promotion and disease prevention specialists, and epidemiologists.

SITC s Guide to Managing Immunotherapy Toxicity

SITC   s Guide to Managing Immunotherapy Toxicity
Author: Marc S. Ernstoff, MD,Igor Puzanov, MD, MSCI, FACP,Caroline Robert, MD, PhD,Adi M. Diab, MD,Peter M. Hersey, MD, PhD
Publsiher: Springer Publishing Company
Total Pages: 250
Release: 2019-03-15
ISBN 10: 0826172156
ISBN 13: 9780826172150
Language: EN, FR, DE, ES & NL

SITC s Guide to Managing Immunotherapy Toxicity Book Review:

The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers. With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care. Key Features: Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy Provides numerous tables that condense and highlight pertinent information for quick reference Describes the various clinical presentations and toxic reactions caused by immunotherapy Purchase includes access to the eBook for use on most mobile devices or computer

ESMO Handbook of Cancer in the Senior Patient

ESMO Handbook of Cancer in the Senior Patient
Author: Dirk Schrijvers,Matti Aapro,Branko Zakotnik,Riccardo Audisio,Hendrik van Halteren,Hurria Arti
Publsiher: CRC Press
Total Pages: 168
Release: 2010-05-20
ISBN 10: 1841847488
ISBN 13: 9781841847481
Language: EN, FR, DE, ES & NL

ESMO Handbook of Cancer in the Senior Patient Book Review:

The incidence of cancer in senior patients has been increasing worldwide. This book reflects the state of the art in the management of senior adults with cancer. The contributors discuss epidemiology, evaluation, surgical and radiotherapy treatment, hormonal and cytotoxic treatment, and specific cancers such as lung, breast, colorectal, prostate, bladder, gynecological, and renal cell cancer. The book also examines psychological, social, and ethical aspects, as well as the role of the multidisciplinary team. Designed to help clinicians with the delicate decision-making process, it should lead to the best therapy adapted not only to the disease but also the patient.

ESMO Handbook of Cancer Diagnosis and Treatment Evaluation

ESMO Handbook of Cancer Diagnosis and Treatment Evaluation
Author: Hans-Joachim Schmoll,Laura Van't Meer,Jan Vermorken,Dirk Schrijvers
Publsiher: CRC Press
Total Pages: 160
Release: 2009-02-20
ISBN 10: 0203092104
ISBN 13: 9780203092101
Language: EN, FR, DE, ES & NL

ESMO Handbook of Cancer Diagnosis and Treatment Evaluation Book Review:

An informative handbook on the staging of cancer and the selection and evaluation of cancer treatment. ESMO Handbook on Treatment Evaluation in Cancer is an ideal resource for medical oncologists and those involved in screening and chemotherapy programs. The text demonstrates how to judge various prognostic and predictive factors, how to determine the relevance of staging, and how to measure patient response for each cancer type. Written by an international team of experts, this progressive text incorporates the fast-moving world of research into the field of cancer genetics and prevention. Topics discussed include: epidemiology genetics of cancer sporadic cancers hereditary cancers primary prevention of cancer screening programmes for the general population screening programmes for those at higher risk the role of prevention secondary prevention of cancer

Chimeric Antigen Receptor T Cell Therapies for Cancer E Book

Chimeric Antigen Receptor T Cell Therapies for Cancer E Book
Author: Daniel W. Lee,Nirali N. Shah
Publsiher: Elsevier Health Sciences
Total Pages: 244
Release: 2019-11-30
ISBN 10: 0323755976
ISBN 13: 9780323755979
Language: EN, FR, DE, ES & NL

Chimeric Antigen Receptor T Cell Therapies for Cancer E Book Book Review:

From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.

Handbook of Cancer Survivorship Care

Handbook of Cancer Survivorship Care
Author: Dr. Maria Alma Rodriguez, MD,Dr. Lewis E. Foxhall, MD
Publsiher: Springer Publishing Company
Total Pages: 256
Release: 2018-08-28
ISBN 10: 082613825X
ISBN 13: 9780826138255
Language: EN, FR, DE, ES & NL

Handbook of Cancer Survivorship Care Book Review:

Handbook of Cancer Survivorship Care serves as a practical and concise guide for the multidisciplinary management of cancer survivors. Nearly all of the chapters are authored by a team consisting of a seasoned oncologist and an experienced practitioner who provides direct services in survivorship care. Chapters reflect the importance of interdisciplinary collaboration and cover the high-yield pearls and clinical applications that lead to quality patient care outcomes. Part I discusses the basic concepts of survivorship care, models of care, and clinical tools while addressing late and long-term effects of treatment, screening methods for secondary or recurring tumors, and prevention of disease relapse. Part II includes chapters on cancers commonly seen in community practice, such as breast, prostate, lymphoma, and colorectal. Chapters in Part II provide clinical pearls and disease-specific background, a guide to disease surveillance, instructions for monitoring late effects, early detection tips, and information on psychosocial health, all to better direct clinical assessment and management. With cancer survivors an increasing segment of the healthcare population and survivorship care rapidly evolving, it is paramount that oncologists and other care providers are up-to-date on the clinical strategies, interventions, and recommendations for follow-up care. As a pocket-sized, quick reference, Handbook of Cancer Survivorship Care is an indispensable resource for any healthcare provider – including physicians, nurses, and other practitioners – seeing patients in remission; it covers the must-know points of clinical management and successfully carries over cutting-edge expertise into clinical practice whether it is used at the bedside or in the clinic. Key Features: Includes practical guidance on challenging areas such as addressing psychosocial issues, establishing screening and prevention strategies, managing late effects in cancer survivors and many more Easy-to-read outline format makes referencing in the clinical setting quick and convenient Practical clinical vignettes with self-assessment Q&A accompany chapters in Part II Clinical pearls highlight survivorship guidelines and their application Provides management guidelines and detailed disease surveillance strategies for site-specific cancers Includes digital access to the e-book

Preclinical Development Handbook

Preclinical Development Handbook
Author: Shayne Cox Gad
Publsiher: John Wiley & Sons
Total Pages: 1080
Release: 2008-03-21
ISBN 10: 9780470249048
ISBN 13: 0470249048
Language: EN, FR, DE, ES & NL

Preclinical Development Handbook Book Review:

A clear, straightforward resource to guide you through preclinical drug development Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic,comprehensive reference to prioritizing and optimizing leads, toxicity, pharmacogenomics, modeling, and regulations. This single definitive, easy-to-use resource discusses all the issues that need consideration and provides detailed instructions for current methods and techniques. Each chapter was written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor, with more than thirty years' experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear. Among the key topics covered are: * In vitro mammalian cytogenetics tests * Phototoxicity * Carcinogenicity studies * The pharmacogenomics of personalized medicine * Bridging studies * Toxicogenomics and toxicoproteomics Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage. This is a hands-on guide for pharmaceutical scientists involved in preclinical testing,enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.

Cancer and Aging Handbook

Cancer and Aging Handbook
Author: Keith M. Bellizzi,Margot Gosney
Publsiher: John Wiley & Sons
Total Pages: 536
Release: 2012-07-20
ISBN 10: 1118312481
ISBN 13: 9781118312483
Language: EN, FR, DE, ES & NL

Cancer and Aging Handbook Book Review:

A state-of-the-art, multidisciplinary approach to cancer and aging With the majority of cancers occurring in individuals over the age of 65 against a backdrop of an expanding aging population, there is an urgent need to integrate the areas of clinical oncology and geriatric care. This timely work tackles these issues head-on, presenting a truly multidisciplinary and international perspective on cancer and aging from world-renowned experts in geriatrics, oncology, behavioral science, psychology, gerontology, and public health. Unlike other books on geriatric oncology that focus mainly on treatment, Cancer and Aging Handbook: Research and Practice examines all phases of the cancer care continuum, from prevention through evidence-based diagnosis and treatment to end-of-life care. Detailed clinical and research information helps guide readers on effective patient care as well as caregiver training, research, and intervention. Coverage includes: Epidemiology of cancer in older adults, plus the unique physical, mental, and social issues involved Strategies and guidelines for prevention, screening, and treatment of older individuals with cancer The most common cancers in the elderly, including breast, colorectal, lung, prostate, and ovarian cancer Cancer survivorship in older adults as well as the all-critical issues of palliative care and pain management Emerging topics such as caregiver and family issues, different models of care, and cost considerations An essential resource for clinicians and caregivers as well as researchers interested in this evolving field, Cancer and Aging Handbook is also useful for public health professionals and policymakers who need to formulate services and allocate resources for the growing population of older cancer patients.

The Cancer Chemotherapy Handbook

The Cancer Chemotherapy Handbook
Author: David S. Fischer,Mary Kathryn Tish Knobf,M. Tish Knobf,Henry J. Durivage
Publsiher: Mosby Incorporated
Total Pages: 619
Release: 1997
ISBN 10: 1928374650XXX
ISBN 13: UOM:39015040596911
Language: EN, FR, DE, ES & NL

The Cancer Chemotherapy Handbook Book Review:

Concisely written, yet comprehensive in scope, this new edition is a practical guide to the medical care and chemotherapeutic treatment of cancer patients. It is formatted for easy access to the more than 85 specific drugs currently used in cancer treatment. 12 illus.

Handbook of Quality of Life in Cancer

Handbook of Quality of Life in Cancer
Author: Angelos P. Kassianos
Publsiher: Springer Nature
Total Pages: 477
Release: 2022-03-25
ISBN 10: 3030847020
ISBN 13: 9783030847029
Language: EN, FR, DE, ES & NL

Handbook of Quality of Life in Cancer Book Review:

Quality of life is an important outcome when treating a cancer patient. Research is vast on the role of quality of life on patients' general wellbeing, responsiveness to treatment, and even mortality. On the other hand, there are several methodological considerations when planning to measure and assess quality of life in cancer patients. This handbook – with authorship that is diverse in terms of perspectives, countries, and fields – aims to fill a gap in the available literature and responds to a number of questions in its 26 chapters: What is quality of life and health-related quality of life and why are they important? How is quality of life assessed? What are the theoretical and methodological considerations when using quality of life outcomes in cancer research? How is quality of life useful in routine clinical care? How is quality of life impacting different cancer populations in terms of site of the cancer, age, gender, and context? Handbook of Quality of Life in Cancer is a learning and consulting tool that can be used by a diverse audience. It is an essential resource for researchers who wish to use quality of life assessment tools in clinical trials or other types of studies; clinicians who want to develop their understanding of how they can utilize quality of life and how it is important for the patients they care for; and commissioners who wish to see why quality of life may impact population health and health system costs. Students in diverse fields of study (medicine, nursing, psychology, social work, medical sociology, population health, epidemiology, and medical statistics, among others) also would benefit from using the handbook for their studies and for their continuing professional development.

Braddom s Rehabilitation Care A Clinical Handbook

Braddom   s Rehabilitation Care  A Clinical Handbook
Author: David X. Cifu,Henry L. Lew
Publsiher: Elsevier Health Sciences
Total Pages: 448
Release: 2017-12-28
ISBN 10: 0323497330
ISBN 13: 9780323497336
Language: EN, FR, DE, ES & NL

Braddom s Rehabilitation Care A Clinical Handbook Book Review:

Concise and portable, Braddom’s Clinical Handbook of Physical Medicine and Rehabilitation, by Drs. David X. Cifu and Henry L. Lew, gives you dependable, up-to-date content in a handbook format ideally suited for use at the bedside or in outpatient clinics. This quick reference covers the everyday topics you need – assistive devices and orthoses, spasticity, pediatric, adult, and geriatric care, pain management, outcome measures, and much more – all derived from the most trusted name in the field of PM&R. Reader-friendly format with succinct, templated chapters for ease of use. Authoritative content derived from the #1 comprehensive reference in the field: Braddom’s Physical Medicine and Rehabilitation. An ideal resource for the entire rehabilitation team as a quick reference or study guide. Highlights key concepts spanning the full spectrum of rehabilitation medicine to help optimize outcomes for patients with a range of chronic diseases, impairments, and disabilities. Includes eSlides complied by internationally renowned experts to summarize key teaching points and clinical pearls.

Handbook of Breast Cancer and Related Breast Disease

Handbook of Breast Cancer and Related Breast Disease
Author: Katherine H. R. Tkaczuk, MD,Susan B. Kesmodel, MD,Steven J. Feigenberg, MD
Publsiher: Springer Publishing Company
Total Pages: 370
Release: 2016-12-28
ISBN 10: 1617052760
ISBN 13: 9781617052767
Language: EN, FR, DE, ES & NL

Handbook of Breast Cancer and Related Breast Disease Book Review:

Handbook of Breast Cancer and related Breast Disease is a practical guide to the management of patients with breast malignancies and related non-neoplastic lesions. Written and edited by leading experts, this handbook focuses on the application of conventional and novel treatment strategies to the care of patients with nonmalignant breast disease and all stages of breast cancer. The handbook is organized chronologically, from screening, through diagnosis and management, to survivorship care and related medical issues. The bulk of these chapters provide evidence-based treatment strategies for all patient subsets, including how to manage patients with high risk breast lesions, invasive breast carcinoma at each stage, and with all known molecular subtypes of breast cancer. Surgical, radiation, and medical treatment options are all discussed for each stage of breast cancer including treatment approaches in pregnancy and for high risk lesions and Phyllodes. This handbook is a comprehensive yet concise resource for residents, fellows, and early-career practitioners. Community oncologists, breast surgeons, radiation oncologists, primary care practitioners, and OBGYNs will also find its concise review of new research and procedures to be very useful in this dynamic field of medicine. Key Features: Includes discussion of genomic testing in management of early stage breast cancer Covers adjuvant and neoadjuvant treatment approaches Includes short clinical trial reviews for quick update of study endpoints and results for reference in management of breast cancer Outlines strategies for survivorship issues Key points in each chapter highlight clinical pearls and summarize other important concepts

Oxford Handbook of Oncology

Oxford Handbook of Oncology
Author: Jim Cassidy,Donald Bissett,Roy A. J. Spence OBE,Miranda Payne,Gareth Morris-Stiff
Publsiher: OUP Oxford
Total Pages: 896
Release: 2015-08-13
ISBN 10: 0191075027
ISBN 13: 9780191075025
Language: EN, FR, DE, ES & NL

Oxford Handbook of Oncology Book Review:

Now fully revised and in its fourth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students and practitioners in oncology for over a decade. The scientific basis and diagnosis of cancers is covered, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies. The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the emerging data on the importance of the immune response. Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
Author: MiKaela M. Olsen,Kristine B. LeFebvre,Kelly J. Brassil
Publsiher: Unknown
Total Pages: 135
Release: 2018-10-15
ISBN 10: 9781635930207
ISBN 13: 1635930200
Language: EN, FR, DE, ES & NL

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice Book Review:

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice features 26 chapters examining multiple categories of cancer-care agents, including chemotherapy, immunotherapy, molecularly targeted agents, and hormone therapy.

Cardiac Management of Oncology Patients

Cardiac Management of Oncology Patients
Author: Gonzalo Baron Esquivias,Riccardo Asteggiano
Publsiher: Springer
Total Pages: 259
Release: 2015-05-25
ISBN 10: 3319158082
ISBN 13: 9783319158082
Language: EN, FR, DE, ES & NL

Cardiac Management of Oncology Patients Book Review:

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.

Handbook of Metastatic Breast Cancer Second Edition

Handbook of Metastatic Breast Cancer  Second Edition
Author: Charles Swanton,Stephen R. D. Johnston
Publsiher: CRC Press
Total Pages: 302
Release: 2011-11-14
ISBN 10: 1841848123
ISBN 13: 9781841848129
Language: EN, FR, DE, ES & NL

Handbook of Metastatic Breast Cancer Second Edition Book Review:

Recent developments with novel systemic drugs, palliative surgical techniques and diagnostic imaging have given hope for the treatment of patients whose breast cancer has spread beyond its primary tumour. Written by a team from leading cancer centers in Europe, including the UK's Royal Marsden Hospital, the Handbook of Metastatic Breast Cancer, Second Edition provides advanced scientific information and guidance on clinical problems associated with metastatic breast cancer.